Cabio Biotech Wuhan Co Ltd (688089) — Tangible Net Worth Ratio
Cabio Biotech Wuhan Co Ltd (688089) has a Tangible Net Worth Ratio of 97.4% as of September 2025. This metric is calculated by deducting intangible assets (CN¥41.88 Million) from net assets (CN¥1.64 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Cabio Biotech Wuhan Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cabio Biotech Wuhan Co Ltd Tangible Net Worth Ratio (2013–2024)
This chart shows how Cabio Biotech Wuhan Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 97.4%, reflecting net assets of CN¥1.64 Billion with intangible assets of CN¥41.88 Million CNY. For live market cap and overall valuation, see how much is Cabio Biotech Wuhan Co Ltd worth.
Annual Tangible Net Worth Ratio for Cabio Biotech Wuhan Co Ltd (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Cabio Biotech Wuhan Co Ltd from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 688089 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.3% | CN¥1.57 Billion | CN¥43.09 Million | CN¥1.69 Billion | ▲ +0.0 pp |
| 2023 | 97.2% | CN¥1.49 Billion | CN¥41.08 Million | CN¥1.61 Billion | ▼ -0.2 pp |
| 2022 | 97.5% | CN¥1.43 Billion | CN¥36.34 Million | CN¥1.61 Billion | ▼ -1.6 pp |
| 2021 | 99.0% | CN¥1.38 Billion | CN¥13.15 Million | CN¥1.45 Billion | ▲ +0.1 pp |
| 2020 | 98.9% | CN¥1.32 Billion | CN¥14.54 Million | CN¥1.38 Billion | ▲ +0.0 pp |
| 2019 | 98.9% | CN¥1.25 Billion | CN¥14.30 Million | CN¥1.30 Billion | ▲ +3.4 pp |
| 2018 | 95.5% | CN¥526.20 Million | CN¥23.86 Million | CN¥581.19 Million | ▲ +0.9 pp |
| 2017 | 94.6% | CN¥464.39 Million | CN¥25.21 Million | CN¥506.37 Million | ▲ +1.2 pp |
| 2016 | 93.4% | CN¥402.60 Million | CN¥26.51 Million | CN¥476.78 Million | ▼ -1.6 pp |
| 2015 | 95.0% | CN¥354.83 Million | CN¥17.66 Million | CN¥440.43 Million | ▼ -1.0 pp |
| 2014 | 96.0% | CN¥465.90 Million | CN¥18.60 Million | CN¥507.41 Million | ▲ +1.6 pp |
| 2013 | 94.4% | CN¥428.24 Million | CN¥23.89 Million | CN¥467.92 Million | — |